Emerging in the arena of weight management treatment, retatrutide is a different strategy. Unlike many existing medications, retatrutide works as a dual agonist, concurrently targeting both glucagon-like peptide-1 (GLP-1) and glucose-responsive insulinotropic substance (GIP) sensors. The simultaneous activation fosters multiple beneficial effects, … Read More